Literature DB >> 13573582

The effectiveness of long-term treatment of malignant hypertension.

H P DUSTAN, R E SCHNECKLOTH, A C CORCORAN, I H PAGE.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy

Mesh:

Year:  1958        PMID: 13573582     DOI: 10.1161/01.cir.18.4.644

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Clinical connotations of the experimental hypertensions.

Authors:  A C CORCORAN
Journal:  Can Med Assoc J       Date:  1959-08-01       Impact factor: 8.262

2.  Guanethidine as the sole agent in the treatment of hypertension.

Authors:  G R CUMMING; B SWAIN
Journal:  Can Med Assoc J       Date:  1961-01-28       Impact factor: 8.262

3.  Severe hypertension treated with ganglion-blocking drugs in a general hospital.

Authors:  J D NORTH; J C WILLIAMS; R N HOWIE
Journal:  Br Med J       Date:  1961-05-20

4.  Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

Authors:  M HARINGTON; P KINCAID-SMITH; J McMICHAEL
Journal:  Br Med J       Date:  1959-11-14

5.  Results of Hypotensive Therapy in Arterial Hypertension.

Authors:  J V Hodge; E G McQueen; H Smirk
Journal:  Br Med J       Date:  1961-01-07

6.  Guanethidine in the treatment of hypertension.

Authors:  K N PALMER; G A McDONALD
Journal:  Postgrad Med J       Date:  1962-06       Impact factor: 2.401

Review 7.  Hyperpiesis: high blood-pressure without evident cause: essential hypertension.

Authors:  G Pickering
Journal:  Br Med J       Date:  1965-10-30

8.  The value of antihypertensive therapy.

Authors:  E D Freis
Journal:  Bull N Y Acad Med       Date:  1969-09

9.  Biofeedback-aided relaxation and meditation in the management of hypertension.

Authors:  C H Patel
Journal:  Biofeedback Self Regul       Date:  1977-03

10.  Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial.

Authors: 
Journal:  Br Med J       Date:  1973-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.